Adult orbital xanthogranuloma: long-term follow-up of treated cases.

Sanne E DetigerG J HötteRobert M VerdijkR O B de KeizerP M van HagenJ A M van LaarD Paridaens

Published in: Eye (London, England) (2022)

Recognition of AOXGD is important, in particular, because of the potential severe systemic locations in the different subtypes. Surgical excision might be a sufficient therapy for patients with AOX. Patients with AAPOX, NBX, and ECD warrant systemic therapy. Currently, there is no conclusive evidence for a superior treatment strategy, but further studies are necessary to investigate treatment options.

Keyphrases

early onset
drug induced
stem cells
human health
risk assessment
mesenchymal stem cells
climate change
bone marrow